Literature DB >> 15579776

Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents.

Régis Coutant1, Florence Boux de Casson, Stéphanie Rouleau, Olivier Douay, Elisabeth Mathieu, Frédérique Gatelais, Natacha Bouhours-Nouet, Christelle Voinot, Maurice Audran, Jean Marie Limal.   

Abstract

The lower responsiveness to GH in women than in men is probably due to a divergent effect of gonadal steroids. It is unknown, however, how the progressive increase in sex steroid production that occurs during puberty affects this responsiveness. To compare the effects of puberty and sex steroid administration on responsiveness to GH, we used the IGF-I generation test, in which the peak IGF-I level 24 h after a single injection of GH (2 mg/m2) was studied in 117 healthy short subjects (56 females and 61 males). The subjects, aged 8-16 yr, were divided into four groups: prepuberty, early puberty, midpuberty, or pubertal delay. In the latter group, the IGF-I response was determined before and after priming with oral 17beta-estradiol in girls and im testosterone in boys. We also tested for an association between body composition (by dual energy x-ray absorptiometry) and the IGF-I response to GH. The IGF-I increment in response to GH (change in IGF-I from baseline) was correlated with the growth velocity sd score (P < 0.05). Progression throughout puberty was associated with an increase in both baseline IGF-I (P < 0.05) and the IGF-I increment in response to GH (P < 0.05), with no gender difference. Pubertal category (pre-, early, and midpuberty; P < 0.05) and fat percentage (P < 0.05) were the main positive predictors of the IGF-I increment in response to GH, expressed as micrograms per liter as well as sd score, independently of baseline IGF-I. After sex steroid priming, both the GH peak in response to insulin-induced hypoglycemia and baseline IGF-I were increased (P < 0.05, after vs. before sex steroid). However, the IGF-I increment in response to GH decreased after oral 17beta-estradiol (P < 0.05), whereas it was unchanged after testosterone administration. Endogenous gonadal steroid secretion appears to result in increased responsiveness to GH in peripubertal girls and boys. By contrast, exogenous estrogen and testosterone, respectively, produce a relative decrease and no change in responsiveness to GH in similar populations, possibly through the achievement of sex steroid concentrations exceeding physiological ranges for age. Fat percentage was a positive determinant of the responsiveness to GH, suggesting a link between the energy stores and the anabolic action of GH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579776     DOI: 10.1210/jc.2004-0814

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Marjorie McCracken; Eric Vittinghoff
Journal:  Inflamm Bowel Dis       Date:  2011-02-01       Impact factor: 5.325

Review 2.  Obesity and the pubertal transition in girls and boys.

Authors:  Christine M Burt Solorzano; Christopher R McCartney
Journal:  Reproduction       Date:  2010-09       Impact factor: 3.906

3.  Genome-wide screening in human growth plates during puberty in one patient suggests a role for RUNX2 in epiphyseal maturation.

Authors:  Joyce Emons; Bas E Dutilh; Eva Decker; Heide Pirzer; Carsten Sticht; Norbert Gretz; Gudrun Rappold; Ewan R Cameron; James C Neil; Gary S Stein; Andre J van Wijnen; Jan Maarten Wit; Janine N Post; Marcel Karperien
Journal:  J Endocrinol       Date:  2011-02-09       Impact factor: 4.286

4.  Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period.

Authors:  Talita Poli Biason; Tamara Beres Lederer Goldberg; Cilmery Suemi Kurokawa; Maria Regina Moretto; Altamir Santos Teixeira; Hélio Rubens de Carvalho Nunes
Journal:  BMC Endocr Disord       Date:  2015-04-03       Impact factor: 2.763

5.  Dynamic alterations in linear growth and endocrine parameters in children with obesity and height reference values.

Authors:  Elena Kempf; Mandy Vogel; Tim Vogel; Jürgen Kratzsch; Kathrin Landgraf; Andreas Kühnapfel; Ruth Gausche; Daniel Gräfe; Elena Sergeyev; Roland Pfäffle; Wieland Kiess; Juraj Stanik; Antje Körner
Journal:  EClinicalMedicine       Date:  2021-06-23

6.  Growth hormone protects against ovariectomy-induced bone loss in states of low circulating insulin-like growth factor (IGF-1).

Authors:  J Christopher Fritton; Kelly B Emerton; Hui Sun; Yuki Kawashima; Wilson Mejia; Yingjie Wu; Clifford J Rosen; David Panus; Mary Bouxsein; Robert J Majeska; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

7.  The influence of estrogens on the biological and therapeutic actions of growth hormone in the liver.

Authors:  Mercedes de Mirecki-Garrido; Borja Guerra; Carlos Mateos-Díaz; Roberto Jiménez-Monzón; Nicolás Díaz-Chico; Juan C Díaz-Chico; Leandro Fernández-Pérez
Journal:  Pharmaceuticals (Basel)       Date:  2012-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.